Joan Mannick

Person

Cambridge, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Treatment of cancer using a CD123 chimeric antigen receptor
- Patent number 11,591,404
- Issue date Feb 28, 2023
- Novartis AG
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Regulatable chimeric antigen receptor
- Patent number 11,578,130
- Issue date Feb 14, 2023
- Novartis AG
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Anti-BCMA chimeric antigen receptor
- Patent number 11,084,880
- Issue date Aug 10, 2021
- Novartis AG
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods of enhancing immune response
- Patent number 11,045,463
- Issue date Jun 29, 2021
- Novartis AG
- Joan Mannick
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of enhancing immune response
- Patent number 10,993,940
- Issue date May 4, 2021
- Novartis AG
- Joan Mannick
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Biomarkers predictive of therapeutic responsiveness to chimeric ant...
- Patent number 10,774,388
- Issue date Sep 15, 2020
- Novartis AG
- Felipe Bedoya
- G01 - MEASURING TESTING
Information Patent Grant
Treatment of cancer using a CD123 chimeric antigen receptor
- Patent number 10,703,819
- Issue date Jul 7, 2020
- The Trustees of the University of Pennsylvania
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination therapies
- Patent number 10,596,165
- Issue date Mar 24, 2020
- RESTORBIO, INC.
- Joan Mannick
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical combination of everolimus with dactolisib
- Patent number 10,576,076
- Issue date Mar 3, 2020
- Novartis AG
- David Glass
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of cancer using a CLL-1 chimeric antigen receptor
- Patent number 10,568,947
- Issue date Feb 25, 2020
- Novartis AG
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of enhancing immune response
- Patent number 10,441,584
- Issue date Oct 15, 2019
- Novartis AG
- Joan Mannick
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of cancer using anti-CD19 Chimeric Antigen Receptor
- Patent number 10,357,514
- Issue date Jul 23, 2019
- The Trustees of the University of Pennsylvania
- Carl H. June
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Low, immune enhancing, dose MTOR inhibitors and uses thereof
- Patent number 10,286,069
- Issue date May 14, 2019
- Novartis AG
- Joan Mannick
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Regulatable chimeric antigen receptor
- Patent number 10,287,354
- Issue date May 14, 2019
- Novartis AG
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Nucleic acid encoding a humanized anti-BCMA chimeric antigen receptor
- Patent number 10,174,095
- Issue date Jan 8, 2019
- Novartis AG
- Jennifer Brogdon
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Low, immune enhancing, dose mtor inhibitors and uses thereof
- Patent number 10,004,803
- Issue date Jun 26, 2018
- Novartis AG
- Joan Mannick
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of cancer using a CD123 chimeric antigen receptor
- Patent number 9,815,901
- Issue date Nov 14, 2017
- Novartis AG
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR
- Publication number 20230220090
- Publication date Jul 13, 2023
- Novartis AG
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
REGULATABLE CHIMERIC ANTIGEN RECEPTOR
- Publication number 20230026049
- Publication date Jan 26, 2023
- Novartis AG
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TREATMENT OF CANCER USING HUMANIZED ANTI-BCMA CHIMERIC ANTIGEN RECE...
- Publication number 20220064316
- Publication date Mar 3, 2022
- The Trustees of the University of Pennsylvania
- Jennifer Brogdon
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BIOMARKERS PREDICTIVE OF THERAPEUTIC RESPONSIVENESS TO CHIMERIC ANT...
- Publication number 20210172020
- Publication date Jun 10, 2021
- Novartis AG
- Felipe Bedoya
- G01 - MEASURING TESTING
Information Patent Application
PHARMACEUTICAL COMBINATION OF EVEROLIMUS WITH DACTOLISIB
- Publication number 20210030741
- Publication date Feb 4, 2021
- Novartis AG
- David Glass
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR
- Publication number 20210002377
- Publication date Jan 7, 2021
- Novartis AG
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS FOR B CELL PRECONDITIONING IN CAR THERAPY
- Publication number 20200339651
- Publication date Oct 29, 2020
- Novartis AG
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER USING A CLL-1 CHIMERIC ANTIGEN RECEPTOR
- Publication number 20200215171
- Publication date Jul 9, 2020
- Novartis AG
- Jennifer Brogdon
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF ENHANCING IMMUNE RESPONSE
- Publication number 20200061051
- Publication date Feb 27, 2020
- Novartis AG
- Joan Mannick
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LOW, IMMUNE ENHANCING, DOSE MTOR INHIBITORS AND USES THEREOF
- Publication number 20200054742
- Publication date Feb 20, 2020
- Novartis AG
- Joan MANNICK
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS OF ENHANCING IMMUNE RESPONSE
- Publication number 20200054624
- Publication date Feb 20, 2020
- Novartis AG
- Joan Mannick
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER USING ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR
- Publication number 20190388471
- Publication date Dec 26, 2019
- Novartis AG
- Carl H. June
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
REGULATABLE CHIMERIC ANTIGEN RECEPTOR
- Publication number 20190263914
- Publication date Aug 29, 2019
- Novartis AG
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMBINATION THERAPIES
- Publication number 20190247386
- Publication date Aug 15, 2019
- resTORbio, Inc.
- Joan Mannick
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER USING 5 HUMANIZED ANTI-BCMA CHIMERIC ANTIGEN RE...
- Publication number 20190153061
- Publication date May 23, 2019
- Novartis AG
- Jennifer Brogdon
- C07 - ORGANIC CHEMISTRY
Information Patent Application
LOW, IMMUNE ENHANCING, DOSE MTOR INHIBITORS AND USES THEREOF
- Publication number 20180369370
- Publication date Dec 27, 2018
- Novartis AG
- Joan MANNICK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR B CELL PRECONDITIONING IN CAR THERAPY
- Publication number 20180334490
- Publication date Nov 22, 2018
- Jennifer Brogdon
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR
- Publication number 20180312595
- Publication date Nov 1, 2018
- Novartis AG
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
PHARMACEUTICAL COMBINATION OF EVEROLIMUS WITH DACTOLISIB
- Publication number 20180289694
- Publication date Oct 11, 2018
- David Glass
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF ENHANCING IMMUNE RESPONSE
- Publication number 20180161319
- Publication date Jun 14, 2018
- Novartis AG
- Joan Mannick
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHOSPHOGLYCERATE KINASE 1 (PGK) PROMOTERS AND METHODS OF USE FOR EX...
- Publication number 20180118834
- Publication date May 3, 2018
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
BIOMARKERS PREDICTIVE OF THERAPEUTIC RESPONSIVENESS TO CHIMERIC ANT...
- Publication number 20170306416
- Publication date Oct 26, 2017
- Felipe Bedoya
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
LOW, IMMUNE ENHANCING, DOSE MTOR INHIBITORS AND USES THEREOF
- Publication number 20170281753
- Publication date Oct 5, 2017
- NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC.
- Joan MANNICK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATIONS OF LOW, IMMUNE ENHANCING, DOSES OF MTOR INHIBITORS AND...
- Publication number 20170274014
- Publication date Sep 28, 2017
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
REGULATABLE CHIMERIC ANTIGEN RECEPTOR
- Publication number 20160311907
- Publication date Oct 27, 2016
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TREATMENT OF CANCER USING A CD33 CHIMERIC ANTIGEN RECEPTOR
- Publication number 20160096892
- Publication date Apr 7, 2016
- The Trustees of the University of Pennsylvania
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR
- Publication number 20160068601
- Publication date Mar 10, 2016
- The Trustees of the University of Pennsylvania
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER USING A CLL-1 CHIMERIC ANTIGEN RECEPTOR
- Publication number 20160051651
- Publication date Feb 25, 2016
- The Trustees of the University of Pennsylvania
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER USING HUMANIZED ANTI-BCMA CHIMERIC ANTIGEN RECE...
- Publication number 20160046724
- Publication date Feb 18, 2016
- The Trustees of the University of Pennsylvania
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER USING ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR
- Publication number 20150283178
- Publication date Oct 8, 2015
- Carl H. June
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Joan Mannick

Person

Patents Grantslast 30 patents

Treatment of cancer using a CD123 chimeric antigen receptor

Regulatable chimeric antigen receptor

Anti-BCMA chimeric antigen receptor

Methods of enhancing immune response

Methods of enhancing immune response

Biomarkers predictive of therapeutic responsiveness to chimeric ant...

Treatment of cancer using a CD123 chimeric antigen receptor

Combination therapies

Pharmaceutical combination of everolimus with dactolisib

Treatment of cancer using a CLL-1 chimeric antigen receptor

Methods of enhancing immune response

Treatment of cancer using anti-CD19 Chimeric Antigen Receptor

Low, immune enhancing, dose MTOR inhibitors and uses thereof

Regulatable chimeric antigen receptor

Nucleic acid encoding a humanized anti-BCMA chimeric antigen receptor

Low, immune enhancing, dose mtor inhibitors and uses thereof

Treatment of cancer using a CD123 chimeric antigen receptor

Patents Applicationslast 30 patents

TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR

REGULATABLE CHIMERIC ANTIGEN RECEPTOR

TREATMENT OF CANCER USING HUMANIZED ANTI-BCMA CHIMERIC ANTIGEN RECE...

BIOMARKERS PREDICTIVE OF THERAPEUTIC RESPONSIVENESS TO CHIMERIC ANT...

PHARMACEUTICAL COMBINATION OF EVEROLIMUS WITH DACTOLISIB

TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR

METHODS FOR B CELL PRECONDITIONING IN CAR THERAPY

TREATMENT OF CANCER USING A CLL-1 CHIMERIC ANTIGEN RECEPTOR

METHODS OF ENHANCING IMMUNE RESPONSE

LOW, IMMUNE ENHANCING, DOSE MTOR INHIBITORS AND USES THEREOF

METHODS OF ENHANCING IMMUNE RESPONSE

TREATMENT OF CANCER USING ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR

REGULATABLE CHIMERIC ANTIGEN RECEPTOR

COMBINATION THERAPIES

TREATMENT OF CANCER USING 5 HUMANIZED ANTI-BCMA CHIMERIC ANTIGEN RE...

LOW, IMMUNE ENHANCING, DOSE MTOR INHIBITORS AND USES THEREOF

METHODS FOR B CELL PRECONDITIONING IN CAR THERAPY

TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR

PHARMACEUTICAL COMBINATION OF EVEROLIMUS WITH DACTOLISIB

METHODS OF ENHANCING IMMUNE RESPONSE

PHOSPHOGLYCERATE KINASE 1 (PGK) PROMOTERS AND METHODS OF USE FOR EX...

BIOMARKERS PREDICTIVE OF THERAPEUTIC RESPONSIVENESS TO CHIMERIC ANT...

LOW, IMMUNE ENHANCING, DOSE MTOR INHIBITORS AND USES THEREOF

COMBINATIONS OF LOW, IMMUNE ENHANCING, DOSES OF MTOR INHIBITORS AND...

REGULATABLE CHIMERIC ANTIGEN RECEPTOR

TREATMENT OF CANCER USING A CD33 CHIMERIC ANTIGEN RECEPTOR

TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR

TREATMENT OF CANCER USING A CLL-1 CHIMERIC ANTIGEN RECEPTOR

TREATMENT OF CANCER USING HUMANIZED ANTI-BCMA CHIMERIC ANTIGEN RECE...

TREATMENT OF CANCER USING ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR